NFKB1 and cancer: Enhanced expression of NF‐κB was documented in about 60 chronic inflammatory diseases and states, known as “NF‐κB diseases,” whereas constitutive activation of NF‐κB was documented also in human cancer cells, pointing its high sensitivity to different stimuli that can activate it, as well as several biological responses it may control (Adler et al. 2007; Amiri and Richmond 2005; Kunnumakkara et al. 2020).